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LETTER TO THE EDITOR
Surgical Management
of an Inoperable Giant
Pleomorphic
Rhabdomyosarcoma of
the Chest Wall
To the Editor:
A 65-year-old men was referred to
our hospital with a complaint of giant
mass on the chest wall, which reached
its present size to 3 cm in 5 months. On
physical examination, the mass was firm,
fixed, necrotized, and nontender (Figure
1). Metastatic lesions were detected in the
lung. An incisional biopsy of the tumor
confirmed the diagnosis of pleomorphic
rhabdomyosarcoma, 2 months ago in an-
other clinic. The patient was considered as
inoperable because the lung was meta-
static, and the mass excision was not
performed. Serous leakage, observed in
the incision area, was irritating for the
patient. The patient brought to our clinic
for the mass excision. The mass was
totally excised. The size of the tumor
was 16  16  15 cm, and the weight
was 1750 g. The chest wall and the
axillary skin defect were reconstructed
with a latissimus dorsi muscle flap. The
skin was primarily closed. After the op-
eration, the patient has received chemo-
therapy in an oncological center. The
postoperative course was uneventful,
and no recurrence was found. The pa-
tient is still alive after 6 months fol-
low-up and was satisfied from the opera-
tion. Surgical excision has not seemed to
contribute to the improvement in survival
after the mainstay of local disease control
on chest wall rhabdomyosarcoma.1 The
excision of giant tumors is usually not
preferred because of its hardness, and it
is useless for survival. Still, resection of
giant mass can improve the patient’s
condition and may provide a good qual-
ity of life.2
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Acute Renal Failure
in a Patient Receiving
Anti-VEGF Therapy for
Advanced Non-small
Cell Lung Cancer
To the Editor:
Bevacizumab, a monoclonal hybrid
antibody that binds to and neutralizes vas-
cular endothelial growth factor, has shown
promising efficacy in the adjunctive treat-
ment of patients with several cancers.
However, significant side effects are asso-
ciated with bevacizumab, especially hy-
pertention and proteinuria, but rarely acute
renal failure. Here, we report a 67-year-
old man, habitted smoker, who developed
new-onset acute renal failure after receiv-
ing bevacizumab for stage IV non-small
cell lung cancer. On January 16, 2008,
treatment with paclitaxel 300 mg (175
mg/m2), carboplatin 580 mg (AUC  6)
plus bevacizumab 900 mg (15 mg/kg)
intravenously every 3 weeks was initiated.
During the first two cycles, the patient’s
serum creatinine was stable at approxi-
mately 76 mol/liter and urinalysis was
unremarkable. On March 2, 2008, his se-
rum creatinine level was 461 mol/liter.
Then he had a progressive increase in
creatinine levels and became oliguric re-
quiring intermittent hemodialysis. Dys-
morphic red blood cells and a few coarse
granular casts were presented in the urine
sediment. Twenty-four hour urine total
protein was 9.47 g. So, the scheduled third
cycle was withheld. Other laboratory tests
including liver function, coagulation sta-
tus, autoimmune antibodies, etc. showed
normal. Kidney ultrasound showed en-
hanced echo signal in cortex area and
normal sized kidneys with no hydrone-
phrosis. Renal vessels were normal. For-
tunately, the patient’s renal function con-
tinued to improve and dialysis was no
longer required. And the treatment for
non-small cell lung cancer was changed to
Gefitinib 250 mg once per day because of
PD proven by computed tomography. An
ultrasound-guided renal biopsy was de-
layed until the patient became more clin-
ically stable. In kidney biopsy, glomeruli
were characterized by intense glomerular
hypercellularity. Much of this hypercellu-
larity was mesangial and segmental
endothelial proliferation, giving the
glomerular tuft a ‘lobular’ appearance
(Figure 1A). The glomerular basement
membrane thickening with the appear-
ance of double contours was caused by
mesangial cell and mesangial matrix
interposition into the subendothelial
zone of the capillary loops, which
caused capillary loops narrow and oc-
cluded (Figure 1B). Immuno-fluores-
cence microscopy showed bright dif-
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FIGURE 1. Giant mass on the left axil-
lary and thorax wall.
Journal of Thoracic Oncology • Volume 4, Number 9, September 2009 1185
